logo-loader
RNS
AdvancedAdvT Ltd

Purchase of Own Shares

RNS Number : 4425A
AdvancedAdvT Limited
26 October 2026
 

This announcement contains inside information
for the purposes of UK Market Abuse Regulation.

 

26 October 2026

AdvancedAdvT Limited

Purchase of Own Shares

AdvancedAdvT Limited (AIM: ADVT, “AdvT”, the “Group”, the “Company”), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces that further to the confirmation of its intention to renew its share buyback programme, as set out in its announcement on 16 September 2026, in the period from 19 October 2026 up to and including 23 October 2026, it purchased a further 350,000 of its ordinary shares of no par value in the capital of the Company (“Ordinary Shares”). The Ordinary Shares purchased will be held in treasury.

 

Following this purchase, the cumulative number of Ordinary Shares purchased under the Company’s buyback programmes since 4 March 2026 is 7,811,453.

 

Aggregated information

 

Date of purchase

Number of Ordinary Shares purchased

Highest price paid per Ordinary Share

Lowest price paid per Ordinary Share

Volume Weighted price paid per Ordinary Share

19 October 2026

150,000

 182.500p

 182.500p

 182.500p

20 October 2026

150,000

 182.500p

 182.000p

 182.333p

21 October 2026

50,000

 180.000p

 180.000p

 180.000p

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

 

Date of purchase

Number of Ordinary Shares purchased

Transaction price

Time of transaction

Trading venue

 19 October 2026

100,000

182.500p

15:44

AIMX

 19 October 2026

50,000

182.500p

08:17

AIMX

 20 October 2026

50,000

182.000p

15:35

AIMX

 20 October 2026

100,000

182.500p

09:08

AIMX

 21 October 2026

50,000

180.000p

14:36

AIMX

 

Total voting rights

 

Following the purchase, the Company's total issued share capital will consist of 137,125,806 Ordinary Shares each carrying one voting right, of which 7,811,453 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 129,314,353. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The person responsible for arranging the release of this Announcement
on behalf of the Company is Gavin Hugill, Chief Financial Officer.

 

Enquiries:

AdvancedAdvT Limited

 

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

 

 

 

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

James Moat / James Fischer

 

 

 

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

 

 

Note to Editors

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in those sectors where long term digitisation trends are set to transform the workplace for professionals. 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSAKABNCBDKQKB
NO INVESTMENT ADVICE

This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).

Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.

Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.

All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.

This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.

This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read